QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)

Imugene (IMU) News Today

SourceHeadline
bizjournals.com logoCell therapy firm acquires RTP manufacturing facility
bizjournals.com - April 17 at 10:23 AM
finance.yahoo.com logoImugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 million
finance.yahoo.com - April 16 at 1:54 PM
markets.businessinsider.com logoBile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohort
markets.businessinsider.com - April 15 at 8:13 PM
finance.yahoo.com logoBile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohort
finance.yahoo.com - April 15 at 8:13 PM
finance.yahoo.com logoImugene opens enrolment for Bile Tract Cancer expansion study
finance.yahoo.com - April 15 at 3:12 PM
msn.com logoASX Health Stocks: Atomo sells more HIV Self-Tests; Actinogen begins Phase 2b trial on Alzheimer’s
msn.com - April 15 at 12:02 AM
finance.yahoo.com logoCity of Hope Scientists Present Leading-Edge Research at American Association for Cancer Research (AACR) Annual Meeting
finance.yahoo.com - April 10 at 8:25 PM
finanznachrichten.de logoImugene Limited: Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024
finanznachrichten.de - April 9 at 6:38 PM
finance.yahoo.com logoImugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024
finance.yahoo.com - April 9 at 1:37 PM
msn.com logoGuess which ASX 300 healthcare stock is storming higher on Chinese patent news
msn.com - April 3 at 9:41 PM
finance.yahoo.com logoPrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
finance.yahoo.com - March 27 at 6:55 AM
finance.yahoo.com logoU.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for Ensartinib
finance.yahoo.com - March 15 at 4:04 PM
finance.yahoo.com logoPendulum Therapeutics Introduces GLP-1 Probiotic
finance.yahoo.com - March 14 at 7:22 AM
finance.yahoo.com logoUnityPoint in Des Moines releases renderings for mental health expansion
finance.yahoo.com - March 13 at 12:47 PM
finance.yahoo.com logoNovartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune System
finance.yahoo.com - March 13 at 7:47 AM
finance.yahoo.com logoapoQlar enters into Collaboration with Mayo Clinic to Advance Patient Care with Extended Reality Technology
finance.yahoo.com - March 12 at 10:29 AM
finanznachrichten.de logoImugene Limited: Phase 1 onCARlytics solid tumour trial advances to combination arm treatment
finanznachrichten.de - March 11 at 10:49 PM
au.investing.com logoFIVE at FIVE AU: Biggest fall on ASX in eight months
au.investing.com - March 11 at 7:48 AM
au.investing.com logoImugene advances to combination dosing with Phase 1 onCARlytics solid tumour trial
au.investing.com - March 11 at 1:32 AM
afr.com logoBarrenjoey, Canaccord raising for Lake Resources; 39.1pc discount
afr.com - March 10 at 8:31 PM
finance.yahoo.com logoImugene Highlights Recent Achievements and Looks Ahead to Key Upcoming Immuno-oncology Catalysts
finance.yahoo.com - February 22 at 12:13 PM
msn.com logo4 things a doctor who's written best-selling books about aging does daily in the hope of living longer
msn.com - February 20 at 6:14 PM
proactiveinvestors.com logoImugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial
proactiveinvestors.com - February 15 at 2:58 AM
msn.com logoBritish Punjabi doctor leads ground-breaking international trial of bowel cancer vaccine
msn.com - February 3 at 3:28 PM
finance.yahoo.com logoMaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
finance.yahoo.com - January 23 at 8:43 AM
finance.yahoo.com logoImugene's CF33-hNIS (VAXINIA) & MAST Study Featured at ASCO GI Cancers Symposium
finance.yahoo.com - January 19 at 12:18 AM
proactiveinvestors.com logoImugene achieves ‘complete response’ with mid dose cancer trial
proactiveinvestors.com - January 18 at 7:17 PM
fool.com.au logoWhy is ASX 300 healthcare stock Imugene jumping 14% today?
fool.com.au - January 16 at 8:40 PM
msn.com logoASX Health Stocks: Imugene gains on positive early signs from Phase 1 trial
msn.com - January 16 at 8:40 PM
au.investing.com logoImugene well positioned to deliver 2024 milestones
au.investing.com - December 28 at 11:47 PM
morningstar.com logoImugene Ltd IUGNF
morningstar.com - December 20 at 6:18 PM
au.investing.com logoImugene and NeoImmuneTech in alliance to advance cancer treatment
au.investing.com - December 11 at 11:45 PM
finance.yahoo.com logoNeoImmuneTech and Imugene enter into strategic research collaboration to improve cancer treatments
finance.yahoo.com - December 11 at 6:45 PM
proactiveinvestors.com.au logoImugene to open new PD1-Vaxx Phase 2 bowel cancer clinical trial in UK and Australia
proactiveinvestors.com.au - December 7 at 3:43 AM
finance.yahoo.com logoImugene to commence new phase 2 PD1-Vaxx bowel cancer trial
finance.yahoo.com - December 6 at 3:48 PM
proactiveinvestors.com logoImugene to be granted European patent for cancer vaccine
proactiveinvestors.com - December 5 at 10:49 PM
fool.com.au logoWhy Collins Foods, Healius, Imugene, and Link shares are climbing today
fool.com.au - November 29 at 12:40 AM
proactiveinvestors.com logoImugene thrilled as VAXINIA granted FDA Fast Track designation
proactiveinvestors.com - November 27 at 11:58 PM
fool.com.au logoImugene share price jumps 32% on FDA news
fool.com.au - November 27 at 6:58 PM
proactiveinvestors.com.au logoImugene opens higher as novel cancer-killing virus VAXINIA is granted FDA Fast Track designation
proactiveinvestors.com.au - November 27 at 6:58 PM
morningstar.com logoImugene Ltd IMU
morningstar.com - November 16 at 7:22 PM
finance.yahoo.com logoWhile Imugene (ASX:IMU) shareholders have made 304% in 5 years, increasing losses might now be front of mind as stock sheds 12% this week
finance.yahoo.com - November 16 at 7:22 PM
proactiveinvestors.com logoImugene says Azer-cel could be best-in-class Allogeneic CAR T
proactiveinvestors.com - November 13 at 12:27 AM
fool.com.au logoWhy Avita Medical, Imugene, Pantoro, and Tietto shares are pushing higher
fool.com.au - November 10 at 12:52 AM
fool.com.au logoImugene share price jumps 34% on 'major milestone': What is it?
fool.com.au - November 10 at 12:52 AM
au.investing.com logoImugene doses first patient in Phase 1b Allogeneic CAR T Clinical Trial
au.investing.com - November 9 at 7:51 PM
fool.com.au logoWhy Imugene, Lottery Corp, Orica, and Sayona Mining shares are storming higher
fool.com.au - November 9 at 12:12 AM
fool.com.au logoGuess which ASX All Ords stock is up 60% in just two days
fool.com.au - November 8 at 9:11 AM
proactiveinvestors.com.au logoImugene’s positive initial VAXINIA MAST trial data prompts analyst optimism; 46 cents target
proactiveinvestors.com.au - November 8 at 12:54 AM
finance.yahoo.com logoPrecision BioSciences Inc (DTIL) Reports Q3 2023 Financial Results
finance.yahoo.com - November 7 at 9:52 AM
Get Imugene News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMU and its competitors with MarketBeat's FREE daily newsletter.

Henry Kissinger’s chilling AI warning (Ad)

Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.

Just click right here to access this new research 100% free while it’s still available.

IMU Media Mentions By Week

IMU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IMU
News Sentiment

-0.36

0.49

Average
Medical
News Sentiment

IMU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IMU Articles
This Week

6

2

IMU Articles
Average Week

Get Imugene News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (ASX:IMU) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners